A human with biallelic BRCA1 mutations was first reported in 1995, in a woman with breast cancer at age 32 and no other clinical features, described as homozygous for a high penetrance breast/ovarian cancer-associated mutation, but this report was subsequently found to be inaccurate (39). This evidence concerns the gene BRCA1 and ovarian cancer.